Japan’s JCR Pharmaceuticals (TYO: 4552) closed 15% higher after Wednesday’s trading, as it signed a new licensing deal.

New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...

US pharma giant Merck & Co today revealed it has made a bid to acquire UK-based lung therapy company Verona Pharma, sending ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.

Donald Trump has escalated his warnings to the pharmaceutical industry with a pledge to introduce import tariffs as high as ...

Prior to joining Crescent, Dr Pinkas was CSO at Pyxis Oncology (Nasdaq: PYXS), where he established the preclinical research ...

Debra Barker has been named chief medical officer (CMO) at Centauri Therapeutics, a UK immunotherapy company with a ...

San Francisco, USA-based biotech Centivax, which is developing durable, universal vaccines, today announced the close of a ...

Switzerland-based MetP Pharma, pioneer in nose-to-brain drug delivery for nearly two decades, announced new data highlighting ...

The US subsidiary of South Korea-based Celltrion today announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) ...

Diagonal Therapeutics, a US biotech focused on correcting dysregulated signaling with clustering antibodies that address the ...